Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients

10.1002/ijc.33822

Saved in:

Bibliographic Details
Main Authors:	Huang, Yiqing, Soon, Yu Yang, Aminkeng, Folefac, Tay, Sen Hee, Ang, Yvonne, Kee, Adrian CL, Goh, Boon Cher, Wong, Alvin SC, Soo, Ross A
Other Authors:	MEDICINE
Format:	Article
Language:	English
Published:	WILEY 2022
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology immune checkpoint inhibitors immune-related adverse events nonsmall cell lung cancer CHECKPOINT INHIBITORS CHEMOTHERAPY PEMBROLIZUMAB IPILIMUMAB NIVOLUMAB TOXICITY ASSOCIATION CARBOPLATIN COMBINATION BLOCKADE
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/235038
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-235038
record_format	dspace
spelling	sg-nus-scholar.10635-2350382024-11-15T08:50:45Z Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients Huang, Yiqing Soon, Yu Yang Aminkeng, Folefac Tay, Sen Hee Ang, Yvonne Kee, Adrian CL Goh, Boon Cher Wong, Alvin SC Soo, Ross A MEDICINE CANCER SCIENCE INSTITUTE OF SINGAPORE Dr XXX Folefac Aminkeng Science & Technology Life Sciences & Biomedicine Oncology immune checkpoint inhibitors immune-related adverse events nonsmall cell lung cancer CHECKPOINT INHIBITORS CHEMOTHERAPY PEMBROLIZUMAB IPILIMUMAB NIVOLUMAB TOXICITY ASSOCIATION CARBOPLATIN COMBINATION BLOCKADE 10.1002/ijc.33822 INTERNATIONAL JOURNAL OF CANCER 150 4 636-644 2022-12-01T03:13:10Z 2022-12-01T03:13:10Z 2021-10-13 2022-11-30T16:04:23Z Article Huang, Yiqing, Soon, Yu Yang, Aminkeng, Folefac, Tay, Sen Hee, Ang, Yvonne, Kee, Adrian CL, Goh, Boon Cher, Wong, Alvin SC, Soo, Ross A (2021-10-13). Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients. INTERNATIONAL JOURNAL OF CANCER 150 (4) : 636-644. ScholarBank@NUS Repository. https://doi.org/10.1002/ijc.33822 0020-7136 1097-0215 https://scholarbank.nus.edu.sg/handle/10635/235038 en WILEY Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
language	English
topic	Science & Technology Life Sciences & Biomedicine Oncology immune checkpoint inhibitors immune-related adverse events nonsmall cell lung cancer CHECKPOINT INHIBITORS CHEMOTHERAPY PEMBROLIZUMAB IPILIMUMAB NIVOLUMAB TOXICITY ASSOCIATION CARBOPLATIN COMBINATION BLOCKADE
spellingShingle	Science & Technology Life Sciences & Biomedicine Oncology immune checkpoint inhibitors immune-related adverse events nonsmall cell lung cancer CHECKPOINT INHIBITORS CHEMOTHERAPY PEMBROLIZUMAB IPILIMUMAB NIVOLUMAB TOXICITY ASSOCIATION CARBOPLATIN COMBINATION BLOCKADE Huang, Yiqing Soon, Yu Yang Aminkeng, Folefac Tay, Sen Hee Ang, Yvonne Kee, Adrian CL Goh, Boon Cher Wong, Alvin SC Soo, Ross A Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients
description	10.1002/ijc.33822
author2	MEDICINE
author_facet	MEDICINE Huang, Yiqing Soon, Yu Yang Aminkeng, Folefac Tay, Sen Hee Ang, Yvonne Kee, Adrian CL Goh, Boon Cher Wong, Alvin SC Soo, Ross A
format	Article
author	Huang, Yiqing Soon, Yu Yang Aminkeng, Folefac Tay, Sen Hee Ang, Yvonne Kee, Adrian CL Goh, Boon Cher Wong, Alvin SC Soo, Ross A
author_sort	Huang, Yiqing
title	Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients
title_short	Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients
title_full	Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients
title_fullStr	Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients
title_full_unstemmed	Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients
title_sort	risk factors for immune-related adverse events from anti-pd-1 or anti-pd-l1 treatment in an asian cohort of nonsmall cell lung cancer patients
publisher	WILEY
publishDate	2022
url	https://scholarbank.nus.edu.sg/handle/10635/235038
_version_	1821222040308285440

Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients

Similar Items